CMET-36. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS

INTRO/OBJECTIVE: A mutation of the BRAF protein is seen in approximately 50% of melanoma patients. Immune checkpoint inhibitors (ICI) are standard therapy in melanoma patients independent of a patient’s BRAF status. The primary objective of this study is to investigate the impact of BRAF status in p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Barnett, Addison, Sagar, Soumya, Lauko, Adam, (Auston) Wei, Wei, Chao, Samuel, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
CNS Metastasis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847585/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.237
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky